Image pharmaphorum Editor Market Access How the hyperlocal delivery model could empower pharmacists ... The NHS is currently facing significant challenges, including staff shortages, union strikes, supply chain issues, and increasing patient volume. Market Access 12 questions with: Daniel Kohlstaedt Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry. Market Access Around the world in pharma events Stay up to date with key industry meetings and conferences in 2023 Market Access How to solve a problem like DTx in Europe? The promise of digital therapeutics (DTx) has been widely discussed and debated since the term first began to emerge back in the early 2010s. Load more results
Market Access How the hyperlocal delivery model could empower pharmacists ... The NHS is currently facing significant challenges, including staff shortages, union strikes, supply chain issues, and increasing patient volume.
Market Access 12 questions with: Daniel Kohlstaedt Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.
Market Access Around the world in pharma events Stay up to date with key industry meetings and conferences in 2023
Market Access How to solve a problem like DTx in Europe? The promise of digital therapeutics (DTx) has been widely discussed and debated since the term first began to emerge back in the early 2010s.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
